Apollomics APLM
NASDAQ APLM
$22.99 +1.39 (+6.45%)
As of: Oct 22, 2026 · 12:01 PM EDT

Apollomics (APLM) Long-Term Investments (2021 - 2023)

Updated

Apollomics' Long-Term Investments came in at $5.76 million for Q4 2023, down 69.8% from $19.07 million a year earlier.

Analysis

Apollomics (APLM) Long-Term Investments (2021 - 2023) Analysis & Trends

  • Going back by year, Long-Term Investments was $19.07 million in FY2022 (-19.7%) and $23.74 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,170.57 Bn 1,139.16 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 641.68 Bn 560.21 Bn 17.26 Bn -
3 AbbVie 502.16 Bn 475.27 Bn 12.70 Bn 266.00 Mn
4 Merck 375.54 Bn 329.92 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 302.70 Bn 266.69 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 268.54 Bn 242.22 Bn 12.86 Bn 297.00 Mn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn -
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 1.56 Bn
10 Apollomics 33.24 Mn -7.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5.76 Mn
Dec 31, 2022 19.07 Mn
Dec 31, 2021 23.74 Mn
API Access

Apollomics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=APLM&period=max&api_key=YOUR_API_KEY